Rickettsiales: Treatment and management of human disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

When a rickettsiosis is suspected, prompt empiric antibiotic therapy should be initiated. Clinical recognition is key to timely treatment. Early administration of effective antibiotics can quickly abate illness and prevent severe complications. Tetracyclines are the drug class of choice for all these infections, with doxycycline being the preferred agent. Where available, chloramphenicol can be used for spotted fever group rickettsioses, typhus group rickettsioses, and scrub typhus, but the drug is not effective for infections caused by Ehrlichia spp. and Anaplasma phagocytophilum. Other alternative agents are available, but their efficacy against the different genera of this order is not as generalizable as that of tetracyclines.

Original languageEnglish (US)
Title of host publicationRickettsiales
Subtitle of host publicationBiology, Molecular Biology, Epidemiology, and Vaccine Development
PublisherSpringer International Publishing
Pages109-124
Number of pages16
ISBN (Electronic)9783319468594
ISBN (Print)9783319468570
DOIs
StatePublished - Jan 1 2016

Fingerprint

Tetracyclines
Disease Management
Ehrlichia
Anaplasma phagocytophilum
Scrub Typhus
Anti-Bacterial Agents
Epidemic Louse-Borne Typhus
Doxycycline
Chloramphenicol
Infection
Pharmaceutical Preparations
Fever
Therapeutics

Keywords

  • Anaplasmosis
  • Azithromycin
  • Chloramphenicol
  • Doxycycline
  • Ehrlichiosis
  • Fluoroquinolones
  • Rifampin
  • Scrub typhus
  • Spotted fever group rickettsioses
  • Typhus group rickettsioses

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Blanton, L. (2016). Rickettsiales: Treatment and management of human disease. In Rickettsiales: Biology, Molecular Biology, Epidemiology, and Vaccine Development (pp. 109-124). Springer International Publishing. https://doi.org/10.1007/978-3-319-46859-4_5

Rickettsiales : Treatment and management of human disease. / Blanton, Lucas.

Rickettsiales: Biology, Molecular Biology, Epidemiology, and Vaccine Development. Springer International Publishing, 2016. p. 109-124.

Research output: Chapter in Book/Report/Conference proceedingChapter

Blanton, L 2016, Rickettsiales: Treatment and management of human disease. in Rickettsiales: Biology, Molecular Biology, Epidemiology, and Vaccine Development. Springer International Publishing, pp. 109-124. https://doi.org/10.1007/978-3-319-46859-4_5
Blanton L. Rickettsiales: Treatment and management of human disease. In Rickettsiales: Biology, Molecular Biology, Epidemiology, and Vaccine Development. Springer International Publishing. 2016. p. 109-124 https://doi.org/10.1007/978-3-319-46859-4_5
Blanton, Lucas. / Rickettsiales : Treatment and management of human disease. Rickettsiales: Biology, Molecular Biology, Epidemiology, and Vaccine Development. Springer International Publishing, 2016. pp. 109-124
@inbook{0fc2d6195954438d90871d7612b33bf1,
title = "Rickettsiales: Treatment and management of human disease",
abstract = "When a rickettsiosis is suspected, prompt empiric antibiotic therapy should be initiated. Clinical recognition is key to timely treatment. Early administration of effective antibiotics can quickly abate illness and prevent severe complications. Tetracyclines are the drug class of choice for all these infections, with doxycycline being the preferred agent. Where available, chloramphenicol can be used for spotted fever group rickettsioses, typhus group rickettsioses, and scrub typhus, but the drug is not effective for infections caused by Ehrlichia spp. and Anaplasma phagocytophilum. Other alternative agents are available, but their efficacy against the different genera of this order is not as generalizable as that of tetracyclines.",
keywords = "Anaplasmosis, Azithromycin, Chloramphenicol, Doxycycline, Ehrlichiosis, Fluoroquinolones, Rifampin, Scrub typhus, Spotted fever group rickettsioses, Typhus group rickettsioses",
author = "Lucas Blanton",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-46859-4_5",
language = "English (US)",
isbn = "9783319468570",
pages = "109--124",
booktitle = "Rickettsiales",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Rickettsiales

T2 - Treatment and management of human disease

AU - Blanton, Lucas

PY - 2016/1/1

Y1 - 2016/1/1

N2 - When a rickettsiosis is suspected, prompt empiric antibiotic therapy should be initiated. Clinical recognition is key to timely treatment. Early administration of effective antibiotics can quickly abate illness and prevent severe complications. Tetracyclines are the drug class of choice for all these infections, with doxycycline being the preferred agent. Where available, chloramphenicol can be used for spotted fever group rickettsioses, typhus group rickettsioses, and scrub typhus, but the drug is not effective for infections caused by Ehrlichia spp. and Anaplasma phagocytophilum. Other alternative agents are available, but their efficacy against the different genera of this order is not as generalizable as that of tetracyclines.

AB - When a rickettsiosis is suspected, prompt empiric antibiotic therapy should be initiated. Clinical recognition is key to timely treatment. Early administration of effective antibiotics can quickly abate illness and prevent severe complications. Tetracyclines are the drug class of choice for all these infections, with doxycycline being the preferred agent. Where available, chloramphenicol can be used for spotted fever group rickettsioses, typhus group rickettsioses, and scrub typhus, but the drug is not effective for infections caused by Ehrlichia spp. and Anaplasma phagocytophilum. Other alternative agents are available, but their efficacy against the different genera of this order is not as generalizable as that of tetracyclines.

KW - Anaplasmosis

KW - Azithromycin

KW - Chloramphenicol

KW - Doxycycline

KW - Ehrlichiosis

KW - Fluoroquinolones

KW - Rifampin

KW - Scrub typhus

KW - Spotted fever group rickettsioses

KW - Typhus group rickettsioses

UR - http://www.scopus.com/inward/record.url?scp=85029070619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029070619&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-46859-4_5

DO - 10.1007/978-3-319-46859-4_5

M3 - Chapter

AN - SCOPUS:85029070619

SN - 9783319468570

SP - 109

EP - 124

BT - Rickettsiales

PB - Springer International Publishing

ER -